CLAYTON — Grifols announced Tuesday that it had delivered the first batches of a coronavirus treatment for clinical trials.
The medicine provides passive immunity to infected patients and …
for our $.99 per month digital access special!
This content is available in full to subscribers. If you already have an account, log in for continued access.
If you already have an account, log in for continued access.
Current print subscribers can activate a website
account by clicking here.
Please consider supporting community journalism by subscribing.
614 E. Market St. Smithfield, North Carolina 27577 919-284-2295